Discussion Question # 2: Discuss the debates surrounding the CSRL office mission and measures of its success as well as the impact of conflict of interest policies on technology development and commer

****** *********** *** **** ****** **************** ************** and *********** ********** ***** *** ****** ************** NameDue ********** Surrounding *** **** ****** MissionCorporate-sponsoredresearch ***** ********* (CSRL) *** ******* ******* **** *** ******* ******* delivering ******* ************ ** the ******* public *** the ******* ***** ** **** ******* The ******* ****** ** ******* the CSRL ****** should prioritize ****** ************ or ** ** the ******** ** ******* ***** *** the ************** ******* ***** be unclear ***** ** ** **************** ****** ******** **** organizations ******** ** CSRL ******** ****** ******* financial benefits ** *** form ** royalties *** licenses *** ***** has **** ********** ** some *********** or ********* that *** ******* institutional ****** ** ************* *********** as *** way ** keeping *** ********** ****** forward **** ************ * ************* ******** ** *** control of ************ and ************ propertySome ******* ***** that they ************* ******* innovation ******** *** ************ *** *** greater good ** ******* ******* on *** ***** ** ***** ******* *** ************ *** *** **** priorities ** the invention by focusing ******* ** *** invention **** ********* *** **** ******* ***** ********** ***** ********** (West ** ** ***** *** success of **** ** ********** ** *** ********** ** *** ************ ********* ********* investors *** *********** ********* its ********** ** CSR and ********* ** its ********** ************ ** the ********* of ****** ***** The creation of long-term value ** ** ********** ****** that ************* *** *** ** ********* whether *** efforts contribute ** *** ********* success *** ********** of the ******* ***** ** ** ******** ********* ******** ** interest at CSRL ** *** ** ** ************ *********** technology ***************** ********* ***** ** ******** **** ****** **** *** ********* *** *********** **** ********* ***** ** al ***** For ******** ************ **** ** the ************* ******* ******** ***** may ********** *** implementation ** ********** ************ ****** ** ********** ******** ** ******* **** and academic ******* rather **** the ****** benefit ***** ** ** 2004) **** ********** research involving ***** ******** ******** ********* may ** prohibited from receivingsponsored research ******* from a ******* ** ***** *** investigator **** ****** ****** ** * ****** ************* with equity ****** ** innovative *********** *** ** ********* as having * conflict ** ******** because **** are *** ************* ** ******* a ********** **** * ******** of interest may be ************ ** ******* biased ******* **** *** expectation ** financial **** One ** *** ******* **** could contribute ** **** ** ******** was ********* **** ** ******** the ********** ***** *********** *** ** commercialized ***** ********* *** * ***** ** the ********** ******* ***** et ** ***** The company *** the ************ may **** * ******** ** interestinfluenced by ********* ***** rather **** the ********** ** patient ****** * ******** ** ******** *** ***** **** * ********** could *********** ********* the training ** students and ************* fellows ** an investigator's *************** ** ** ***** ************ ******************* ******* ** a ********** may ***** the trainee's ******** **** **** what is ************ ***** career trajectory ***** *** ****** a ******** ** ********************* J *** Ashiya M (2004 *** ** ********** Commercialization ** *** ************* ******* ******** ******* Business School Case *******